MODIFICATION OF THE GLYOXALASE SYSTEM IN DISEASE PROCESSES AND PROSPECTS FOR THERAPEUTIC STRATEGIES

被引:43
作者
THORNALLEY, PJ
机构
关键词
D O I
10.1042/bst0210531
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:531 / 534
页数:4
相关论文
共 49 条
[1]  
ALLEN RE, 1993, BIOCHEM SOC T, V21, pF161
[2]  
APPLE MARTIN A., 1967, CANCER CHEMOTHER REP, V51, P455
[3]  
ATKINS TW, 1989, DIABETES RES CLIN EX, V11, P125
[4]  
BRENNAN M, 1989, J BIOL CHEM, V264, P20953
[5]  
CASAZZA JP, 1984, J BIOL CHEM, V259, P231
[6]   INHIBITION OF GROWTH OF HUMAN LEUKEMIA-60 CELLS BY S-2-HYDROXYACYLGLUTATHIONES AND MONOETHYL ESTER DERIVATIVES [J].
CLELLAND, JD ;
ALLEN, RE ;
THORNALLEY, PJ .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (10) :1953-1959
[7]  
COHEN MP, 1991, PHARM DIABETES, P181
[8]  
Conroy P.J., 1979, CIBA F S, V67, P271
[9]   METABOLISM OF METHYLGLYOXAL IN MICROORGANISMS [J].
COOPER, RA .
ANNUAL REVIEW OF MICROBIOLOGY, 1984, 38 :49-68
[10]   CHEMICAL BASIS OF THE ACTION OF GLYOXALASE-I, AN ANTICANCER TARGET ENZYME [J].
DOUGLAS, KT ;
SHINKAI, S .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1985, 24 (01) :31-44